Publisher Full Text
Covid-19 and exacerbation of psoriasis.Dermatol Ther. 2020 07; 33(4):e13632.DT
Links
MeSH
Pub Type(s)
Letter
Comment
Language
eng
PubMed ID
32436303
Citation
Ozaras, Resat, et al. "Covid-19 and Exacerbation of Psoriasis." Dermatologic Therapy, vol. 33, no. 4, 2020, pp. e13632.
Ozaras R, Berk A, Ucar DH, et al. Covid-19 and exacerbation of psoriasis. Dermatol Ther. 2020;33(4):e13632.
Ozaras, R., Berk, A., Ucar, D. H., Duman, H., Kaya, F., & Mutlu, H. (2020). Covid-19 and exacerbation of psoriasis. Dermatologic Therapy, 33(4), e13632. https://doi.org/10.1111/dth.13632
Ozaras R, et al. Covid-19 and Exacerbation of Psoriasis. Dermatol Ther. 2020;33(4):e13632. PubMed PMID: 32436303.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Covid-19 and exacerbation of psoriasis.
AU - Ozaras,Resat,
AU - Berk,Ahmet,
AU - Ucar,Dilek Hasman,
AU - Duman,Habibe,
AU - Kaya,Fatma,
AU - Mutlu,Huseyin,
Y1 - 2020/06/02/
PY - 2020/04/26/received
PY - 2020/05/13/revised
PY - 2020/05/14/accepted
PY - 2020/5/22/pubmed
PY - 2020/11/20/medline
PY - 2020/5/22/entrez
SP - e13632
EP - e13632
JF - Dermatologic therapy
JO - Dermatol Ther
VL - 33
IS - 4
SN - 1529-8019
UR - https://www.unboundmedicine.com/medline/citation/32436303/Covid_19_and_exacerbation_of_psoriasis_
L2 - https://doi.org/10.1111/dth.13632
DB - PRIME
DP - Unbound Medicine
ER -